We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Provider of VNAs for Oncology Sites Reaches Significant Milestone

By MedImaging International staff writers
Posted on 26 Sep 2016
Print article
Image: The Synapse VNA is provides medical image and information management for enterprises (Photo courtesy of FUJIFILM).
Image: The Synapse VNA is provides medical image and information management for enterprises (Photo courtesy of FUJIFILM).
A large diagnostic imaging products and medical informatics solutions provider has announced that they have reached a milestone in the number of installations of their enterprise-wide medical information and image management Vendor Neutral Archive (VNA).

The company has installed more than 300 of the scalable VNA storage systems, used for managing cancer treatment data, at oncology sites around the world. The VNA manages all DICOM (Digital Imaging and Communications in Medicine) and non-DICOM clinical oncology department data, used in the treatment of cancer patients. The data includes radiology diagnostic images, radiation treatment plans, and other clinical data. The oncology facilities that use the Synapse VNA interface more than 800 linear accelerators (linacs).

FUJIFILM Medical Systems U.S.A. (Stamford, CT, USA) developed the Synapse VNA technology interface. The company is also a leading worldwide provider of diagnostic imaging products, and medical informatics solutions, including digital X-Ray systems, Radiology Information Systems (RIS), the Synapse PACS (Picture Archiving and Communication System), cardiovascular products, and advanced imaging systems for the women’s health market. The Synapse VNA enables clinicians to access and securely share the data and back it up, with disaster recovery capabilities.

VP of FUJIFILM Medical Systems TeraMedica Division USA, Greg Strowig, said, “Fujifilm truly dominates the oncology VNA space both for our innovative technology and also our knowledge of what it takes to deliver better cancer care. Cancer centers across the globe have turned to us because of our unparalleled experience with the management of cancer treatment data.”

Related Links:
FUJIFILM Medical Systems U.S.A.

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Silver Member
Radiographic Positioning Equipment
2-Step Multiview Positioning Platform
New
DRF DR & Remote Fluoroscopy Solution
CombiDiagnost R90
Radiology Software
DxWorks

Print article
Radcal

Channels

Radiography

view channel
Image: The new X-ray detector produces a high-quality radiograph (Photo courtesy of ACS Central Science 2024, DOI: https://doi.org/10.1021/acscentsci.4c01296)

Highly Sensitive, Foldable Detector to Make X-Rays Safer

X-rays are widely used in diagnostic testing and industrial monitoring, from dental checkups to airport luggage scans. However, these high-energy rays emit ionizing radiation, which can pose risks after... Read more

MRI

view channel
Image: Artificial intelligence models can be trained to distinguish brain tumors from healthy tissue (Photo courtesy of 123RF)

AI Can Distinguish Brain Tumors from Healthy Tissue

Researchers have made significant advancements in artificial intelligence (AI) for medical applications. AI holds particular promise in radiology, where delays in processing medical images can often postpone... Read more

Nuclear Medicine

view channel
Image: Example of AI analysis of PET/CT images (Photo courtesy of Academic Radiology; DOI: 10.1016/j.acra.2024.08.043)

AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer

Immunotherapy has significantly advanced the treatment of primary lung cancer, but it can sometimes lead to a severe side effect known as interstitial lung disease. This condition is characterized by lung... Read more

General/Advanced Imaging

view channel
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)

AI-Enabled Plaque Assessments Help Cardiologists Identify High-Risk CAD Patients

Groundbreaking research has shown that a non-invasive, artificial intelligence (AI)-based analysis of cardiac computed tomography (CT) can predict severe heart-related events in patients exhibiting symptoms... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.